| TGF-β signaling in diseases | Lifetime | 2 | NL 1 | 99.93 |
| Heterotopic Ossification and Related Conditions | Lifetime | 1 | NL 1 | 99.64 |
| Cancer-related gene regulation | Lifetime | 22 | NL 2 | 99.78 |
| Connective Tissue Growth Factor Research | Lifetime | 2 | NL 1 | 99.67 |
| Kruppel-like factors research | Lifetime | 8 | NL 1 | 99.64 |
| Bone Metabolism and Diseases | Lifetime | 23 | NL 1 | 99.71 |
| Cancer Cells and Metastasis | Lifetime | 45 | NL 3 | 99.65 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 165 | NL 10 | 99.44 |
| Renal and related cancers | Lifetime | 126 | NL 5 | 99.20 |
| Genetic factors in colorectal cancer | Lifetime | 207 | NL 12 | 99.06 |
| Congenital heart defects research | Lifetime | 141 | NL 8 | 98.68 |
| Vascular Anomalies and Treatments | Lifetime | 48 | NL 3 | 98.56 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 895 | NL 25 | 97.92 |
| Angiogenesis and VEGF in Cancer | Lifetime | 569 | NL 18 | 96.72 |
| Liver physiology and pathology | Lifetime | 416 | NL 10 | 96.61 |
| Ubiquitin and proteasome pathways | Lifetime | 929 | NL 20 | 96.46 |
| Metabolism, Diabetes, and Cancer | Lifetime | 922 | NL 17 | 96.97 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 903 | NL 33 | 96.14 |
| Bone health and treatments | Lifetime | 907 | NL 18 | 96.26 |
| Hedgehog Signaling Pathway Studies | Lifetime | 372 | NL 8 | 95.16 |
| Parathyroid Disorders and Treatments | Lifetime | 895 | NL 18 | 95.32 |
| Wnt/β-catenin signaling in development and cancer | Lifetime | 623 | NL 16 | 94.06 |
| Biomarkers in Disease Mechanisms | Lifetime | 268 | NL 6 | 91.37 |
| Connective tissue disorders research | Lifetime | 736 | NL 24 | 93.19 |
| Dupuytren's Contracture and Treatments | Lifetime | 743 | NL 32 | 71.50 |
| TGF-β signaling in diseases | 2021-2025 | 2 | NL 1 | 98.78 |
| Cancer Cells and Metastasis | 2021-2025 | 48 | NL 3 | 97.61 |
| Immune cells in cancer | 2021-2025 | 368 | NL 8 | 93.40 |
| Ubiquitin and proteasome pathways | 2021-2025 | 282 | NL 7 | 90.79 |
| Cancer Research and Treatments | 2021-2025 | 488 | NL 7 | 84.72 |
| Cell Adhesion Molecules Research | 2021-2025 | 741 | NL 36 | 71.91 |